Artelo Biosciences Inc [NASDAQ: ARTL] gained 5.17% or 0.09 points to close at $1.83 with a heavy trading volume of 7460621 shares.
It opened the trading session at $1.78, the shares rose to $1.88 and dropped to $1.6176, the range by which the price of stock traded the whole day. The daily chart for ARTL points out that the company has recorded -72.27% loss over the past six months.
If we look at the average trading volume of 235.16K shares, ARTL reached to a volume of 7460621 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Artelo Biosciences Inc [ARTL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ARTL shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ARTL stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
D. Boral Capital have made an estimate for Artelo Biosciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 08, 2025. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on February 12, 2021, representing the official price target for Artelo Biosciences Inc stock.
Trading performance analysis for ARTL stock
Artelo Biosciences Inc [ARTL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.58. With this latest performance, ARTL shares dropped by -40.97% in over the last four-week period, additionally sinking by -72.27% over the last 6 months – not to mention a drop of -71.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ARTL stock in for the last two-week period is set at 33.88, with the RSI for the last a single of trading hit 0.2191, and the three-weeks RSI is set at 0.3389 for Artelo Biosciences Inc [ARTL]. The present Moving Average for the last 50 days of trading for this stock 3.3772, while it was recorded at 1.7480 for the last single week of trading, and 6.7792 for the last 200 days.
Artelo Biosciences Inc (ARTL) Capital Structure & Debt Analysis
Artelo Biosciences Inc (ARTL) Efficiency & Liquidity Metrics
Artelo Biosciences Inc (ARTL) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Artelo Biosciences Inc. (ARTL) effectively leverages its workforce, generating an average of -$2081666.67 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.38% and a Quick Ratio of 0.38%, indicating strong ability to cover short-term liabilities.
Artelo Biosciences Inc [ARTL]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ARTL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Artelo Biosciences Inc go to 54.18%.
An analysis of Institutional ownership at Artelo Biosciences Inc [ARTL]
There are presently around $1.64%, or 1.64%% of ARTL stock, in the hands of institutional investors.
